GHTF A Boon To Pre-Owned Capital Equipment Market – Commerce Dept.
This article was originally published in The Gray Sheet
The Global Harmonization Task Force's elevation of refurbished medical supply regulation issues "an important development" in lifting barriers for U.S. manufacturers exporting the devices, according to a Sept. 26 report by the U.S. Department of Commerce
You may also be interested in...
FDA has not yet decided whether it will retain premarket exemptions for reprocessed Class I/II single-use devices (SUDs), according to the Aug 2 final guidance "Enforcement Priorities for Single-Use Devices Reprocessed by Third Parties and Hospitals."
Lannett will launch a further seven products in fiscal 2021, after launching four products recently in the first quarter of FY21. The company also plans to pay off its Term Loan ‘A’ in full, by the end of November 2020.
Pfizer has now received a formal European Commission approval for its Nyvepria biosimilar pegfilgrastim. The approval puts the firm in direct competition with several other versions of the Neulasta original.